Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
This study is currently recruiting participants.
Verified April 2013 by Fred Hutchinson Cancer Research Center
Sponsor:
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Collaborators:
Celgene Corporation
Information provided by:
Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier:
NCT01083706
First received: March 8, 2010
Last updated: April 30, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | April 2015 (Final data collection date for primary outcome measure) |